QualityStocks'  Instablog

Send Message
QualityStocks (www.qualitystocks.net) assists publicly traded companies by getting their story out to the investment community while helping investors discover emerging companies with plenty of growth potential. Our name, QualityStocks, emphasizes our commitment to connect subscribers with... More
My company:
My blog:
QualityStocks Micro-Cap and Small-Cap Blog
  • Aastrom Biosciences, Inc. (ASTM) Completes Manufacturing Milestone 0 comments
    Apr 5, 2011 10:22 AM | about stocks: VCEL

    Aastrom Biosciences, Inc., a company who is leading the development of expanded, patient-specific cellular therapies for the treatment of severe cardiovascular disease, announced today that it has completed an important product manufacturing milestone.

    The company has transferred its cell cassette manufacturing to ATEK Medical under the strategic partnership that was announced back in October 2010. The single-use cell cassettes are the central component used in Aastrom’s proprietary culturing process at its facility in Ann Arbor, MI.

    “As a result of this milestone, which we achieved ahead of schedule, we now have a fully validated and reliable manufacturing partner to support our late stage clinical development programs,” remarked Tim Mayleben, president and CEO of Aastrom. “This will ensure that Aastrom has the inventory of high-quality cell cassettes necessary for the planned mid-2011 start of our Phase 3 clinical program in critical limb ischemia.”

    Aastrom also announced today that the U.S. Food and Drug Administration’s Center for Biologics Evaluation and Research formally accepted ixmyelocel-T as the non-proprietary name for the company’s investigational cell therapy product. The decision included approval from United States Adopted Names Council as well.

    Mr. Maylebeen commented, “We also reached an important product development milestone with the selection of ixmyelocel-T as the generic name of our expanded cell therapy product. This name was reviewed and accepted by the FDA and USAN Council and will be used by us and our collaborators going forward.”

    Please see disclaimer on QualityStocks website: disclaimer.qualitystocks.net

    Stocks: VCEL
Back To QualityStocks' Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


More »
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.